01.10.2013 - Fixing ailing drugmaker AstraZeneca remains a work in progress for Chief Executive Pascal Soriot, with sales and profits still heading firmly downhill after his first year in the...
Advertising Opportunities Print, Digital & Content Solutions
LinkedIn | X (Twitter)